Fine on errant ‘Modicare’ insurers

NEW DELHI: The government has introduced tough penal provisions for delay in settlement of insurance claims under its ambitious Ayushman Bharat National Health Protection Scheme (NHPS). Insurance companies may have to pay a hefty penalty as interest to hospitals for delay in payment under the scheme.

According to the model tender document, if claim payment is delayed beyond 15 days, insurance companies will pay a penalty of 1% interest on the claimed amount per week. This will be paid directly by the insurer to the hospital. In case of inter-state claims or portability of benefits, the penalty will become due after 30 days.

Similar penal provisions are also applicable to state health agencies and even on the Centre if they fail to deposit their share of premium to the escrow account or release payments to insurers on time.

The health insurance scheme, popularly known as Modicare, aims to cover nearly 50 crore beneficiaries from over 10.74 crore “deprived” families as per the socio-economic and caste census (SECC) data with an annual health cover of Rs 5 lakh per family per year.

Timely payments have been a major area of concern for healthcare providers. In order to streamline the payment mechanism and avoid delays similar to the Central Government Health Scheme (CGHS), the government has fixed specific time-lines for releasing payments against claims made under the scheme.

Payments to insurers will be released in three different tranches by the state health agencies from a designated escrow account. The Centre and different state governments will deposit their respective premiums into the designated escrow account.

While a hospital can complain to the state health agency if payments are not made on time, the scheme also has a grievance redressal mechanism for insurers if timely payments are not released to them.

Apart from the payment mechanism, the model tender document also details the procedures and packages covered under the scheme as well as those which are not covered and the ones which require pre-authorisation.

For instance, dental procedures, congenital external diseases, vaccinations and fertility-related procedures, along with any ailment or condition that can be treated under outpatient care or OPD will not be covered under the government-run insurance scheme. The scheme will also not cover a person who has attempted suicide or self injury.

While packages covered under the scheme include pre-hospitalisation and post hospitalisation coverage along with drugs, diagnostics and food for patient, the scheme will not cover any out- patient diagnostics and vitamins etc.

Moreover, pre-authorisation is mandated for key procedures including all packages under oncology, cardiology, cardiac surgery and opthalmology. In case of inter-state portability also, pre-authorisation is mandatory.

For administration of the scheme, the tender document divides states into two categories. Category A includes Arunachal, Goa, Himachal, J&K, Manipur, Meghalaya, Mizoram, Nagaland, NCT Delhi, Sikkim, Tripura, Uttarakhand, Andaman and Nicobar Islands, Chandigarh, Dadra and Nagar Haveli, Daman and Diu, Lakshadweep and Puducherry. Category B includes Andhra Pradesh, Assam, Bihar, Chhattisgarh, Gujarat, Haryana, Jharkhand, Karnataka, Kerala, MP, Maharashtra, Odisha, Punjab, Rajasthan, Tamil Nadu, Telangana, UP, and West Bengal.

  • Related Posts

    MNCs seek restart of refurbished medical device imports

    New Delhi, August 19, 2025 — Global med-tech companies have urged the Centre to allow refurbished medical device imports again and include medical devices in India’s repair-services push. The request…

    Kerala’s Disease Surge Tied to Poor Hygiene and Climate Stress

    Thiruvananthapuram, August 19, 2025 — Kerala is seeing a sharp rise in communicable diseases as poor sanitation, stagnant water, and changing weather patterns create ideal conditions for outbreaks. Public-health experts…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

    Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

    Patna HC Rules Phenothiazine & Promethazine Not Narcotic Or Psychotropic Substances Under NDPS Act

    Patna HC Rules Phenothiazine & Promethazine Not Narcotic Or Psychotropic Substances Under NDPS Act

    COMT Inhibitors May Fuel Gut Bacteria That Degrade Levodopa In Parkinson’s Patients

    COMT Inhibitors May Fuel Gut Bacteria That Degrade Levodopa In Parkinson’s Patients

    Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

    Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

    FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

    FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

    IPC releases draft NFI-2026 to promote rational use of medicines

    IPC releases draft NFI-2026 to promote rational use of medicines